| Bennington Health & Rehab | |
| 2 Blackberry Lane, Bennington, Vermont 05201 | |
| (802) 442-8525 | |
| Name | Bennington Health & Rehab |
|---|---|
| Location | 2 Blackberry Lane, Bennington, Vermont |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 100 |
| Occupancy Rate | 64.4% |
| Medicare ID (CCN) | 475027 |
| Legal Business Name | 2 Blackberry Lane Operations Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1063409043 |
| Organization Name | BENNINGTON HEALTH AND REHABILITATION CENTER LLC |
| Doing Business As | BENNINGTON HEALTH AND REHABILITATION CENTER |
| Address | 2 Blackberry Lane, Bennington, VT 05201 |
| Phone Number | 802-442-8525 |
News Archive
Arrayit Corporation announced today that it has sold a third advanced microarray manufacturing system to the University of Texas Southwestern Medical Center at Dallas. The NanoPrint LM60 Microarrayer equipped with Arrayit's Patented Microarray Manufacturing Technology (US Patent 6,101,946) is a computer-driven robotic microarray manufacturing system that enables the screening of 1.5 million lead therapeutic compounds per run, and the NanoPrint LM210 enables more than 5 million.
Mayo Clinic has again broadened the base of its genomic research efforts by establishing a biobank at its Arizona campus, which will support studies in obesity, metabolism and diabetes, all areas of special concern in the Latino population.
The proposed 2.3 percent reduction in (Medicare Advantage plan) payments, which comes on top of cuts already scheduled under the Affordable Care Act, pays no mind to the potential impact on quality of care throughout the program. These cuts will apply to all plans no matter the value they bring in providing quality care to beneficiaries or offering innovative solutions that could ultimately be scaled and applied to the broader program.
Shamir Optical Industry Ltd., a leading provider of innovative products and technology to the ophthalmic lens market, today announced unaudited financial results for the third quarter ended September 30, 2009.
› Verified 1 days ago
| NPI Number | 1831574052 |
| Organization Name | 2 BLACKBERRY LANE OPERATIONS LLC |
| Doing Business As | BENNINGTON HEALTH AND REHABILITATION CENTER |
| Address | 2 Blackberry Ln, Bennington, VT 05201 |
| Phone Number | 802-442-8525 |
News Archive
Arrayit Corporation announced today that it has sold a third advanced microarray manufacturing system to the University of Texas Southwestern Medical Center at Dallas. The NanoPrint LM60 Microarrayer equipped with Arrayit's Patented Microarray Manufacturing Technology (US Patent 6,101,946) is a computer-driven robotic microarray manufacturing system that enables the screening of 1.5 million lead therapeutic compounds per run, and the NanoPrint LM210 enables more than 5 million.
Mayo Clinic has again broadened the base of its genomic research efforts by establishing a biobank at its Arizona campus, which will support studies in obesity, metabolism and diabetes, all areas of special concern in the Latino population.
The proposed 2.3 percent reduction in (Medicare Advantage plan) payments, which comes on top of cuts already scheduled under the Affordable Care Act, pays no mind to the potential impact on quality of care throughout the program. These cuts will apply to all plans no matter the value they bring in providing quality care to beneficiaries or offering innovative solutions that could ultimately be scaled and applied to the broader program.
Shamir Optical Industry Ltd., a leading provider of innovative products and technology to the ophthalmic lens market, today announced unaudited financial results for the third quarter ended September 30, 2009.
› Verified 1 days ago
| NPI Number | 1922872944 |
| Organization Name | BENNINGTON CARE CENTER, LLC |
| Address | 2 Blackberry Ln, Bennington, VT 05201 |
| Phone Number | 802-442-8525 |
News Archive
Arrayit Corporation announced today that it has sold a third advanced microarray manufacturing system to the University of Texas Southwestern Medical Center at Dallas. The NanoPrint LM60 Microarrayer equipped with Arrayit's Patented Microarray Manufacturing Technology (US Patent 6,101,946) is a computer-driven robotic microarray manufacturing system that enables the screening of 1.5 million lead therapeutic compounds per run, and the NanoPrint LM210 enables more than 5 million.
Mayo Clinic has again broadened the base of its genomic research efforts by establishing a biobank at its Arizona campus, which will support studies in obesity, metabolism and diabetes, all areas of special concern in the Latino population.
The proposed 2.3 percent reduction in (Medicare Advantage plan) payments, which comes on top of cuts already scheduled under the Affordable Care Act, pays no mind to the potential impact on quality of care throughout the program. These cuts will apply to all plans no matter the value they bring in providing quality care to beneficiaries or offering innovative solutions that could ultimately be scaled and applied to the broader program.
Shamir Optical Industry Ltd., a leading provider of innovative products and technology to the ophthalmic lens market, today announced unaudited financial results for the third quarter ended September 30, 2009.
› Verified 1 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Arrayit Corporation announced today that it has sold a third advanced microarray manufacturing system to the University of Texas Southwestern Medical Center at Dallas. The NanoPrint LM60 Microarrayer equipped with Arrayit's Patented Microarray Manufacturing Technology (US Patent 6,101,946) is a computer-driven robotic microarray manufacturing system that enables the screening of 1.5 million lead therapeutic compounds per run, and the NanoPrint LM210 enables more than 5 million.
Mayo Clinic has again broadened the base of its genomic research efforts by establishing a biobank at its Arizona campus, which will support studies in obesity, metabolism and diabetes, all areas of special concern in the Latino population.
The proposed 2.3 percent reduction in (Medicare Advantage plan) payments, which comes on top of cuts already scheduled under the Affordable Care Act, pays no mind to the potential impact on quality of care throughout the program. These cuts will apply to all plans no matter the value they bring in providing quality care to beneficiaries or offering innovative solutions that could ultimately be scaled and applied to the broader program.
Shamir Optical Industry Ltd., a leading provider of innovative products and technology to the ophthalmic lens market, today announced unaudited financial results for the third quarter ended September 30, 2009.
› Verified 1 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 18.6 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 10.75 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 40.58 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.43 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 6.01 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 5.58 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 6.3 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 95.38 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 21 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 87.18 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.78 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 28.62 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 20.36 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 7.73 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.24 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 79.58 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 90.67 | 82.93 |
News Archive
Arrayit Corporation announced today that it has sold a third advanced microarray manufacturing system to the University of Texas Southwestern Medical Center at Dallas. The NanoPrint LM60 Microarrayer equipped with Arrayit's Patented Microarray Manufacturing Technology (US Patent 6,101,946) is a computer-driven robotic microarray manufacturing system that enables the screening of 1.5 million lead therapeutic compounds per run, and the NanoPrint LM210 enables more than 5 million.
Mayo Clinic has again broadened the base of its genomic research efforts by establishing a biobank at its Arizona campus, which will support studies in obesity, metabolism and diabetes, all areas of special concern in the Latino population.
The proposed 2.3 percent reduction in (Medicare Advantage plan) payments, which comes on top of cuts already scheduled under the Affordable Care Act, pays no mind to the potential impact on quality of care throughout the program. These cuts will apply to all plans no matter the value they bring in providing quality care to beneficiaries or offering innovative solutions that could ultimately be scaled and applied to the broader program.
Shamir Optical Industry Ltd., a leading provider of innovative products and technology to the ophthalmic lens market, today announced unaudited financial results for the third quarter ended September 30, 2009.
› Verified 1 days ago
Bennington Health & Rehab Location: 2 Blackberry Lane, Bennington, Vermont 05201 Phone: (802) 442-8525 | |
Svhc Centers For Living And Rehabilitation Location: 160 Hospital Drive, Bennington, Vermont 05201 Phone: (802) 447-1547 | |